Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

TORRENT

  • FDA Approval
  • Feb. 29, 2024, 05:36 UTC
  • 40
  • 0 comments

FDA approve ESLICARBAZEPINE ACETATE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • Feb. 29, 2024, 05:36 UTC
  • 34
  • 0 comments

FDA approve MYCOPHENOLIC SODIUM

Comment Full text

APOTEX

  • FDA Approval
  • Feb. 29, 2024, 05:36 UTC
  • 36
  • 0 comments

FDA approve NEBIVOLOL HYDROCHLORIDE

Comment Full text

APOPHARMA A DIV OF APOTEX INC

  • FDA Approval
  • Feb. 28, 2024, 15:23 UTC
  • 40
  • 0 comments

FDA approve LINAGLIPTIN

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Feb. 28, 2024, 15:23 UTC
  • 37
  • 0 comments

FDA approve BRIVARACETAM

Comment Full text

SANDOZ INC

  • FDA Approval
  • Feb. 28, 2024, 15:13 UTC
  • 40
  • 0 comments

FDA approve EDARAVONE

Comment Full text

TEVA PHARMS USA INC

  • FDA Approval
  • Feb. 28, 2024, 15:13 UTC
  • 39
  • 0 comments

FDA approve SUGAMMADEX

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • Feb. 28, 2024, 09:52 UTC
  • 37
  • 0 comments

FDA approve DROSPIRENONE; ETHINYL ESTRADIOL

Comment Full text

INGENUS PHARMS NJ

  • FDA Approval
  • Feb. 28, 2024, 09:52 UTC
  • 34
  • 0 comments

FDA approve ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE

Comment Full text

NOVARTIS

  • FDA Approval
  • Feb. 28, 2024, 09:52 UTC
  • 36
  • 0 comments

FDA approve DABRAFENIB MESYLATE

Comment Full text
  • Previous
  • 539
  • 540
  • 541
  • 542
  • 543
  • Next

Search

News categories

  • Technical Exchange News(11766)
  • Event(4289)
  • SEC News(235879)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143298)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin